{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:17:39Z","timestamp":1793330259463,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Imaging"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jcmg.2017.08.005","type":"journal-article","created":{"date-parts":[[2017,10,2]],"date-time":"2017-10-02T14:15:29Z","timestamp":1506953729000},"page":"1180-1193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":262,"special_numbering":"PA","title":["Role of Cardiac Magnetic Resonance in\u00a0the\u00a0Diagnosis and Prognosis of\u00a0Nonischemic\u00a0Cardiomyopathy"],"prefix":"10.1016","volume":"10","author":[{"given":"Amit R.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmg.2017.08.005_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1532-429X-15-89","article-title":"Impact of cardiovascular magnetic resonance on management and clinical decision-making in heart failure patients","volume":"15","author":"Abbasi","year":"2013","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"Suppl 4","key":"10.1016\/j.jcmg.2017.08.005_bib2","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.2967\/jnumed.114.142729","article-title":"Role of cardiac MR imaging in cardiomyopathies","volume":"56","author":"Kramer","year":"2015","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.jcmg.2017.08.005_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2014.05.027","article-title":"The MOGE(S) classification of cardiomyopathy for clinicians","volume":"64","author":"Arbustini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2017.08.005_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ehjci\/jeu182","article-title":"Histological validation of cardiac magnetic resonance analysis of regional and diffuse interstitial myocardial fibrosis","volume":"16","author":"Iles","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.0000078641.19365.4C","article-title":"Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance","volume":"108","author":"McCrohon","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/eurheartj\/ehi258","article-title":"Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies","volume":"26","author":"Mahrholdt","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"57","author":"Iles","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib9","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/eurheartj\/ehr391","article-title":"Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography","volume":"33","author":"Leong","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jcmg.2017.08.005_bib11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure","volume":"9","author":"Puntmann","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib12","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacc.2012.02.070","article-title":"Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation","volume":"60","author":"Klem","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib13","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1161\/CIRCULATIONAHA.116.026910","article-title":"Association between mid-wall late gadolinium enhancement and sudden cardiac death in patients with dilated cardiomyopathy and mild and moderate left ventricular systolic dysfunction","volume":"135","author":"Halliday","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib14","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"Kober","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcmg.2017.08.005_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1532-429X-13-29","article-title":"Cardiac resynchronization therapy guided by late gadolinium-enhancement cardiovascular magnetic resonance","volume":"13","author":"Leyva","year":"2011","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2017.08.005_bib16","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.jacc.2012.05.054","article-title":"Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy","volume":"60","author":"Leyva","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib17","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New perspectives on the prevalence of hypertrophic cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib18","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1161\/CIRCULATIONAHA.104.507723","article-title":"Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy","volume":"112","author":"Rickers","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2008.04.047","article-title":"Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy","volume":"52","author":"Olivotto","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1136\/heartjnl-2013-305471","article-title":"Role of late gadolinium enhancement cardiovascular magnetic resonance in the risk stratification of hypertrophic cardiomyopathy","volume":"100","author":"Ismail","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jcmg.2017.08.005_bib21","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.jcmg.2016.02.031","article-title":"Prognostic value of LGE-CMR in HCM: a meta-analysis","volume":"9","author":"Weng","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.113.007094","article-title":"Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy","volume":"130","author":"Chan","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib23","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1161\/CIRCIMAGING.112.976738","article-title":"Myocardial tissue characterization using magnetic resonance noncontrast T1 mapping in hypertrophic and dilated cardiomyopathy","volume":"5","author":"Dass","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib24","doi-asserted-by":"crossref","first-page":"e003285","DOI":"10.1161\/CIRCIMAGING.115.003285","article-title":"T1 Mapping in discrimination of hypertrophic phenotypes: hypertensive heart disease and hypertrophic cardiomyopathy: findings from the International T1 Multicenter Cardiovascular Magnetic Resonance Study","volume":"8","author":"Hinojar","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jcmg.2012.08.019","article-title":"Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy","volume":"6","author":"Puntmann","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1161\/CIRCIMAGING.112.000333","article-title":"T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/jce.12948","article-title":"Diffuse ventricular fibrosis on cardiac magnetic resonance imaging associates with ventricular tachycardia in patients with hypertrophic cardiomyopathy","volume":"27","author":"McLellan","year":"2016","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib28","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ahj.2015.05.013","article-title":"Hypertrophic Cardiomyopathy Registry: the rationale and design of an international, observational study of hypertrophic cardiomyopathy","volume":"170","author":"Kramer","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib29","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2005.03.045","article-title":"Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging","volume":"46","author":"Petersen","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1161\/CIRCIMAGING.111.971713","article-title":"Trabeculated (noncompacted) and compact myocardium in adults: the multi-ethnic study of atherosclerosis","volume":"5","author":"Kawel","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib31","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jacc.2016.08.054","article-title":"Left ventricular noncompaction: anatomical phenotype or distinct cardiomyopathy?","volume":"68","author":"Weir-McCall","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib32","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/eurheartj\/ehp595","article-title":"Measurement of trabeculated left ventricular mass using cardiac magnetic resonance imaging in the diagnosis of left ventricular non-compaction","volume":"31","author":"Jacquier","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/eurjhf\/hfq222","article-title":"Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity","volume":"13","author":"Nucifora","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2017.08.005_bib34","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.jacc.2016.08.053","article-title":"Long-term prognostic value of cardiac magnetic resonance in left ventricle noncompaction: a prospective multicenter study","volume":"68","author":"Andreini","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib35","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1161\/CIRCULATIONAHA.104.516716","article-title":"Occult cardiac contractile dysfunction in dystrophin-deficient children revealed by cardiac magnetic resonance strain imaging","volume":"112","author":"Ashford","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib36","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.jacc.2008.12.032","article-title":"Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study","volume":"53","author":"Hor","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12968-016-0244-3","article-title":"Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach","volume":"18","author":"Becker","year":"2016","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2017.08.005_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1532-429X-15-107","article-title":"Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function","volume":"15","author":"Hor","year":"2013","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2017.08.005_bib39","doi-asserted-by":"crossref","first-page":"e001338","DOI":"10.1161\/JAHA.114.001338","article-title":"Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy","volume":"4","author":"Tandon","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcmg.2017.08.005_bib40","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the Task Force Criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcmg.2011.01.005","article-title":"Impact of the revision of arrhythmogenic right ventricular cardiomyopathy\/dysplasia task force criteria on its prevalence by CMR criteria","volume":"4","author":"Vermes","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib42","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jacc.2004.09.053","article-title":"Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging","volume":"45","author":"Tandri","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12968-014-0050-8","article-title":"Arrhythmogenic right ventricular cardiomyopathy (ARVC): cardiovascular magnetic resonance update","volume":"16","author":"te Riele","year":"2014","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2017.08.005_bib44","doi-asserted-by":"crossref","first-page":"e003647","DOI":"10.1161\/CIRCIMAGING.115.003647","article-title":"Right ventricular strain and dyssynchrony assessment in arrhythmogenic right ventricular cardiomyopathy: cardiac magnetic resonance feature-tracking study","volume":"8","author":"Prati","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib45","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib46","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.amjcard.2013.03.027","article-title":"Predictors of cardiac sarcoidosis using commonly available cardiac studies","volume":"112","author":"Freeman","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0002-8703(99)70115-8","article-title":"Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies","volume":"138","author":"Uemura","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib48","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jcmg.2017.08.005_bib49","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jacc.2005.01.047","article-title":"Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis","volume":"45","author":"Smedema","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib50","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1378\/chest.128.3.1629","article-title":"The additional value of gadolinium-enhanced MRI to standard assessment for cardiac involvement in patients with pulmonary sarcoidosis","volume":"128","author":"Smedema","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.jcmg.2017.08.005_bib51","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurjhf\/hfr099","article-title":"Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study","volume":"13","author":"Patel","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcmg.2017.08.005_bib52","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1161\/CIRCULATIONAHA.109.851352","article-title":"Detection of myocardial damage in patients with sarcoidosis","volume":"120","author":"Patel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib53","doi-asserted-by":"crossref","first-page":"e003738","DOI":"10.1161\/CIRCIMAGING.115.003738","article-title":"Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance","volume":"9","author":"Murtagh","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib54","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib55","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jcmg.2012.10.021","article-title":"CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis","volume":"6","author":"Greulich","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib56","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.amjcard.2014.01.434","article-title":"Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias","volume":"113","author":"Cain","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib57","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1164\/rccm.201309-1668LE","article-title":"Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping","volume":"189","author":"Crouser","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcmg.2017.08.005_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijcard.2016.04.158","article-title":"Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use","volume":"217","author":"Mavrogeni","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib59","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1093\/eurheartj\/ehm193","article-title":"Cardiac involvement in systemic inflammatory diseases","volume":"28","author":"Knockaert","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib60","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1136\/ard.2008.098053","article-title":"Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus","volume":"68","author":"O\u2019Neill","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jcmg.2017.08.005_bib61","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jcmg.2014.03.012","article-title":"Coronary vessel wall contrast enhancement imaging as a potential direct marker of coronary involvement: integration of findings from CAD and SLE patients","volume":"7","author":"Varma","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcmg.2010.09.019","article-title":"Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus","volume":"4","author":"Ishimori","year":"2011","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib63","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijcard.2014.07.016","article-title":"Heart failure imaging patterns in systemic lupus erythematosus: evaluation using cardiovascular magnetic resonance","volume":"176","author":"Mavrogeni","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib64","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1177\/0961203315622275","article-title":"Prevalence, distribution and clinical correlates of myocardial fibrosis in systemic lupus erythematosus: a cardiac magnetic resonance study","volume":"25","author":"Seneviratne","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.jcmg.2017.08.005_bib65","first-page":"1330e5","article-title":"Atrioventricular heart block and syncope coincident with diagnosis of systemic lupus erythematosus","volume":"29","author":"Prochaska","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib66","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10554-006-9161-0","article-title":"Utility of cardiac MRI for diagnosis and post-treatment follow-up of lupus myocarditis","volume":"23","author":"Saremi","year":"2007","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib67","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/0961203308089401","article-title":"Myocardial tissue characterization in systemic lupus erythematosus: value of a comprehensive cardiovascular magnetic resonance approach","volume":"17","author":"Abdel-Aty","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.jcmg.2017.08.005_bib68","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.07.182","article-title":"Native T1 and T2 mapping by CMR in lupus myocarditis: disease recognition and response to treatment","volume":"222","author":"Hinojar","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1191\/0961203305lu2050oa","article-title":"Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report","volume":"14","author":"Singh","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.jcmg.2017.08.005_bib70","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1161\/CIRCIMAGING.112.000151","article-title":"Native myocardial T1 mapping by cardiovascular magnetic resonance imaging in subclinical cardiomyopathy in patients with systemic lupus erythematosus","volume":"6","author":"Puntmann","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib71","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jacc.2007.10.049","article-title":"Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy","volume":"51","author":"Vogelsberg","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib72","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2007.08.028","article-title":"Evaluation and management of the cardiac amyloidosis","volume":"50","author":"Selvanayagam","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcmg.2017.08.005_bib73","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib74","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib75","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib76","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib77","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib78","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib79","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/eurheartj\/ehu444","article-title":"T1 mapping and survival in systemic light-chain amyloidosis","volume":"36","author":"Banypersad","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib80","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2017.08.005_bib81","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib82","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1182\/blood-2003-06-1919","article-title":"Myocardial iron loading in transfusion-dependent thalassemia and sickle cell disease","volume":"103","author":"Wood","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcmg.2017.08.005_bib83","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jcmg.2008.04.005","article-title":"Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia","volume":"1","author":"Leonardi","year":"2008","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jcmg.2017.08.005_bib84","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major","volume":"120","author":"Kirk","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jcmg.2017.08.005_bib85","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/j.ehj.2003.09.017","article-title":"Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: evidence for a disease specific abnormality of the myocardial interstitium","volume":"24","author":"Moon","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcmg.2017.08.005_bib86","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib87","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCIMAGING.113.000482","article-title":"T(1) mapping with cardiovascular MRI is highly sensitive for Fabry disease independent of hypertrophy and sex","volume":"6","author":"Thompson","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jcmg.2017.08.005_bib88","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12968-014-0099-4","article-title":"Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance","volume":"16","author":"Pica","year":"2014","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.jcmg.2017.08.005_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/hrt.2006.104026","article-title":"Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa","volume":"94","author":"Hughes","year":"2008","journal-title":"Heart"}],"container-title":["JACC: Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X17307763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936878X17307763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:44:15Z","timestamp":1761846255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936878X17307763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":89,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1936878X17307763"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmg.2017.08.005","relation":{},"ISSN":["1936-878X"],"issn-type":[{"value":"1936-878X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Cardiac Magnetic Resonance in\u00a0the\u00a0Diagnosis and Prognosis of\u00a0Nonischemic\u00a0Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmg.2017.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}